Tousignant Jennifer 4/A

What Happened
Jennifer Tousignant, Chief Legal Officer of Viridian Therapeutics (VRDN), disposed of 1,675 shares on March 3, 2026. The shares were recorded at $30.19 each, for a total value of $50,568. The transaction is coded F, indicating the shares were used to satisfy a tax liability (withholding), not an open-market directional sale.

Key Details

• Transaction date and price: 2026-03-03 at $30.19 per share.
• Shares disposed: 1,675; total value: $50,568.
• Transaction code: F — payment of exercise price or tax liability (share withholding to cover taxes).
• Filing status: This is an amended Form 4 filed 2026-03-09 correcting the number of shares and price sold to cover taxes reported on the initial Form 4 (filed March 4, 2026). The amendment also corrects the resulting total number of shares beneficially owned after the reported transactions.
• Timeliness: Amendment filed; no late-timeliness code provided.

Context
Code F activity typically reflects routine tax withholding tied to equity awards or option exercises and does not necessarily signal a view on the company’s prospects. The amendment here corrects reported amounts from the initial filing; see the amended Form 4 for the updated post-transaction beneficial ownership total.